Cc1ccc2[nH]c(/C(C#N)=C\c3cc(C)n(-c4cccc([N+](=O)[O-])c4)c3C)nc2c1
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?